High Quality Undervalued Stocks

Results

193

38 new
This selection of undervalued companies are the market's hidden engines of wealth. Not only do they combine good cash flows with and a solid balance sheet, but they are also poised for a breakout.

193 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MRK
US$119.523.8%50.7%US$298.3bUS$129.7433.021.2%2.8%Pharmaceuticals & Biotech
STX
US$876.77-4.8%573.6%US$191.7bUS$871.0983.437.3%0.3%Tech
APP
US$563.69-8.1%46.9%US$187.2bUS$648.1048.421.7%n/aSoftware
WDC
US$526.93-3.5%824.1%US$176.4bUS$537.0928.617.6%0.1%Tech
AIR
€176.962.2%6.9%€139.3b€209.7427.815.7%1.8%Capital Goods
6098
JP¥10,755.00-1.3%29.9%JP¥15.0tJP¥11,225.0030.112.0%0.2%Commercial Services
MELI
US$1,611.99-6.9%-34.2%US$81.5bUS$2,216.9642.626.9%0%Retail
4519
JP¥7,465.00-2.6%-3.8%JP¥12.3tJP¥9,973.3327.212.4%1.8%Pharmaceuticals & Biotech
LITE
US$895.40-1.1%990.5%US$67.2bUS$1,113.01158.779.1%n/aTech
RHM
€1,199.80-0.6%-32.4%€55.9b€1,889.3853.230.8%1.0%Capital Goods
NU
New
US$11.60-10.7%-2.7%US$58.2bUS$18.484.519.9%n/aBanks
SE
US$84.49-11.3%-48.7%US$53.0bUS$140.5032.324.0%n/aRetail
GALD
CHF 166.901.8%44.0%CHF 39.1bCHF 184.3080.224.3%0.2%Pharmaceuticals & Biotech
FITB
US$51.967.0%31.3%US$47.1bUS$57.521.522.3%3.1%Banks
300476
CN¥314.80-8.0%212.3%CN¥306.9bCN¥439.4066.150.6%0.6%Tech
CSU
New
CA$2,962.391.0%-39.3%CA$62.9bCA$3,939.1560.617.7%0.2%Software
2345
NT$2,420.00-3.6%228.4%NT$1.4tNT$2,902.0045.832.8%0.6%Tech
STLD
US$267.202.1%100.0%US$38.7bUS$255.9128.122.5%0.8%Materials
RDDT
US$171.13-3.8%45.6%US$33.4bUS$224.9246.625.4%n/aMedia
2408
NT$339.50-11.0%556.7%NT$1.1tNT$344.3630.445.5%0.4%Semiconductors
ADYEN
€833.30-8.6%-51.2%€26.3b€1,390.8124.715.6%n/aDiversified Financials
P
US$73.77-12.6%32.8%US$24.0bUS$93.74108.428.4%n/aTech
AS
New
US$33.88-5.4%-10.1%US$19.8bUS$49.7243.123.2%n/aConsumer Durables
STMN
CHF 95.181.4%-10.8%CHF 15.2bCHF 107.1142.516.0%1.1%Healthcare
Page 1 of 6